These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 36709279)

  • 1. A prognostic model based on necroptosis-related genes for prognosis and therapy in bladder cancer.
    Wang Z; Huang Z; Cao X; Zhang F; Cai J; Tang P; Yang C; Li S; Yu D; Yan Y; Shen B
    BMC Urol; 2023 Jan; 23(1):10. PubMed ID: 36709279
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MLKL and other necroptosis-related genes promote the tumor immune cell infiltration, guiding for the administration of immunotherapy in bladder urothelial carcinoma.
    Zhong B; Wang Y; Liao Y; Liang J; Wang K; Zhou D; Zhao Y; Jiang N
    Apoptosis; 2023 Jun; 28(5-6):892-911. PubMed ID: 37000317
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predicting Prognosis and Distinguishing Cold and Hot Tumors in Bladder Urothelial Carcinoma Based on Necroptosis-Associated lncRNAs.
    Liu D; Xu S; Chang T; Ma S; Wang K; Sun G; Chen S; Xu Y; Zhang H
    Front Immunol; 2022; 13():916800. PubMed ID: 35860239
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of molecular subtypes, risk signature, and immune landscape mediated by necroptosis-related genes in non-small cell lung cancer.
    Zhu J; Wang J; Wang T; Zhou H; Xu M; Zha J; Feng C; Shen Z; Jiang Y; Chen J
    Front Oncol; 2022; 12():955186. PubMed ID: 35965497
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognosis Risk Model Based on Necroptosis-Related Signature for Bladder Cancer.
    Chen Z; Cao R; Wang R; Wang Y; Shang D; Tian Y
    Genes (Basel); 2022 Nov; 13(11):. PubMed ID: 36421795
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification and Quantification of Necroptosis Landscape on Therapy and Prognosis in Kidney Renal Clear Cell Carcinoma.
    Xin S; Mao J; Duan C; Wang J; Lu Y; Yang J; Hu J; Liu X; Guan W; Wang T; Wang S; Liu J; Song W; Song X
    Front Genet; 2022; 13():832046. PubMed ID: 35237304
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel model based on necroptosis-related genes for predicting immune status and prognosis in glioma.
    Yuan YS; Jin X; Chen L; Liao JM; Zhang Y; Yu KW; Li WK; Cao SW; Huang XZ; Kang CM
    Front Immunol; 2022; 13():1027794. PubMed ID: 36389690
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis and identification of the necroptosis landscape on therapy and prognosis in bladder cancer.
    Zhao Z; Jiang N; Zhang Y; Bai Y; Liu T; Li T; Guo H; Yang R
    Front Genet; 2022; 13():919829. PubMed ID: 36246597
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel necroptosis-related gene index for predicting prognosis and a cold tumor immune microenvironment in stomach adenocarcinoma.
    Khan M; Lin J; Wang B; Chen C; Huang Z; Tian Y; Yuan Y; Bu J
    Front Immunol; 2022; 13():968165. PubMed ID: 36389725
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and validation of a necroptosis-related gene prognostic score to predict prognosis and efficiency of immunotherapy in gastric cancer.
    Xia Y; Zhang R; Wang M; Li J; Dong J; He K; Guo T; Ju X; Ru J; Zhang S; Sun Y
    Front Immunol; 2022; 13():977338. PubMed ID: 36159818
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comprehensive analysis of anoikis-related long non-coding RNA immune infiltration in patients with bladder cancer and immunotherapy.
    Zhang YY; Li XW; Li XD; Zhou TT; Chen C; Liu JW; Wang L; Jiang X; Wang L; Liu M; Zhao YG; Li SD
    Front Immunol; 2022; 13():1055304. PubMed ID: 36505486
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Construction and validation of a bladder cancer risk model based on autophagy-related genes.
    Shen C; Yan Y; Yang S; Wang Z; Wu Z; Li Z; Zhang Z; Lin Y; Li P; Hu H
    Funct Integr Genomics; 2023 Jan; 23(1):46. PubMed ID: 36689018
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A multi-omics-based investigation of the prognostic and immunological impact of necroptosis-related mRNA in patients with cervical squamous carcinoma and adenocarcinoma.
    Zou J; Lin Z; Jiao W; Chen J; Lin L; Zhang F; Zhang X; Zhao J
    Sci Rep; 2022 Oct; 12(1):16773. PubMed ID: 36202899
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comprehensive Characterization of Necroptosis-Related lncRNAs in Bladder Cancer Identifies a Novel Signature for Prognosis Prediction.
    XiaYu K; GuoGang C; CanXuan L; WeiBin X
    Dis Markers; 2022; 2022():2360299. PubMed ID: 35711565
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinicopathological and Prognostic Value of Necroptosis-Associated lncRNA Model in Patients with Kidney Renal Clear Cell Carcinoma.
    Gu J; He Z; Huang Y; Luan T; Chen Z; Wang J; Ding M
    Dis Markers; 2022; 2022():5204831. PubMed ID: 35664432
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comprehensive
    Xu T; Xu W; Zheng Y; Li X; Cai H; Xu Z; Zou Q; Yu B
    Front Immunol; 2022; 13():931906. PubMed ID: 35958598
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cuproptosis scoring system to predict the clinical outcome and immune response in bladder cancer.
    Song Q; Zhou R; Shu F; Fu W
    Front Immunol; 2022; 13():958368. PubMed ID: 35990642
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comprehensive Profiling Reveals Prognostic and Immunogenic Characteristics of Necroptosis in Soft Tissue Sarcomas.
    Qi L; Xu R; Ren X; Zhang W; Yang Z; Tu C; Li Z
    Front Immunol; 2022; 13():877815. PubMed ID: 35663937
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification and Verification of Necroptosis-Related Gene Signature With Prognosis and Tumor Immune Microenvironment in Ovarian Cancer.
    Wang Z; Chen G; Dai F; Liu S; Hu W; Cheng Y
    Front Immunol; 2022; 13():894718. PubMed ID: 35812403
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Construction and validation of a necroptosis-related lncRNAs prognosis signature of hepatocellular carcinoma.
    Peng Y; Wu G; Qiu X; Luo Y; Zou Y; Wei X; Li A
    Front Genet; 2022; 13():916024. PubMed ID: 36110223
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.